Medical Devices Africa

Africa Newborn Screening Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Africa Newborn Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $18.5 Mn Placeholder estimate
Estimate 2025 $20.5 Mn 1.7% of the global market
Projected 2034 $51.1 Mn 149.6% Adds $30.6 Mn over 9 forecast years
CAGR 2025–2034 10.7% Faster than 54% of 173 Medical Devices markets here
Key players 5
  • Africa is 1.72% of the global market.
  • Among regions, the largest is North America at $567.9 Mn.
  • Fastest growing: Africa (this report) at 10.7% a year.
  • Africa ranks 6th of 6 by size among regions.

Market size projection

Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$30.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Newborn Screening Market market size by year, Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $18.5 Mn — —
2025 (base) $20.5 Mn +$2.0 Mn —
2026 (forecast) $22.7 Mn +$2.2 Mn +10.7%
2027 (forecast) $25.1 Mn +$2.4 Mn +22.5%
2028 (forecast) $27.8 Mn +$2.7 Mn +35.7%
2029 (forecast) $30.7 Mn +$3.0 Mn +50.2%
2030 (forecast) $34.0 Mn +$3.3 Mn +66.2%
2031 (forecast) $37.7 Mn +$3.6 Mn +84%
2032 (forecast) $41.7 Mn +$4.0 Mn +103.7%
2033 (forecast) $46.2 Mn +$4.5 Mn +125.5%
2034 (forecast) $51.1 Mn +$4.9 Mn +149.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Africa Newborn Screening Market Analysis at a glance
Market size, 2025$20.5 Mn placeholder estimate
Forecast, 2034$51.1 Mn placeholder estimate
Growth (CAGR), 2025–203410.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, technology and end user (see all)
Key playersRevvity, Natus Medical, Trivitron Healthcare, Bio-Rad Laboratories, Masimo Corporation (see all)
Regulator in AfricaAMASource: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Africa Newborn Screening Market Analysis Executive Summary

Newborn screening tests babies shortly after birth for rare but serious conditions such as metabolic, hormone and genetic disorders.

Key segments of the newborn Screening market include test (Dried Blood Spot Tests, Hearing Screening and Pulse Oximetry) and technology (Tandem Mass Spectrometry, Immunoassays and DNA Assays).

Bar chart: Africa Newborn Screening market size, 2024–2034, placeholder estimates. $18.5 Mn in 2024, $20.5 Mn in 2025 and $51.1 Mn in 2034, 10.7% CAGR.
Africa Newborn Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Africa Newborn Screening Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the newborn Screening market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the newborn Screening market.

Competitive Landscape for Newborn Screening Market in Africa

The newborn Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Newborn Screening Market in Africa

Newborn Screening in Africa: rules and payment

The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.⁠[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)⁠[2], PPB (Kenya)⁠[3] and SAHPRA (South Africa)⁠[4]. How care is paid for in some of these countries: universal health insurance (Egypt)⁠[5], the SHA (Kenya)⁠[6] and planned National Health Insurance (South Africa)⁠[7].

[1] African Union, African Medicines Agency treaty. Checked 14 Nov 2026.

[2] Egyptian Drug Authority. Checked 14 Nov 2026.

[3] Pharmacy and Poisons Board. Checked 14 Nov 2026.

[4] South African Health Products Regulatory Authority. Checked 14 Nov 2026.

[5] Universal Health Insurance Authority. Checked 14 Nov 2026.

[6] Social Health Authority. Checked 14 Nov 2026.

[7] National Department of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how newborn Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Newborn Screening right now, from free public sources.

Patients

Newborn deaths (first 28 days), per 1,000 live births (World Bank)
CountryValueYear
Burkina Faso23.82024
DR Congo23.62024
Egypt13.92024
Ethiopia25.22024
Ghana18.12024
Kenya20.72024
Malawi23.62024
Mali28.02024
Morocco9.62024
Mozambique25.12024
Niger32.82024
Nigeria39.02024
South Africa12.42024
Sudan23.72024
Tanzania19.92024
Uganda21.32024
Zambia21.42024
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Newborn Screening in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Newborn Screening market in Africa?
Placeholder estimate: about $20.5 Mn in 2025, rising to about $51.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Newborn Screening market in Africa growing?
Placeholder estimate: about 10.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Newborn Screening market report cover?
The report splits the market by test (Dried Blood Spot Tests, Hearing Screening, Pulse Oximetry, Genomic Screening), technology (Tandem Mass Spectrometry, Immunoassays, DNA Assays) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Newborn Screening market?
Key players include Revvity, Natus Medical, Trivitron Healthcare, Bio-Rad Laboratories and Masimo Corporation.
What is driving the Newborn Screening market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.
Who regulates Newborn Screening in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How much research is published on Newborn Screening?
PubMed lists 3,809 papers on Newborn Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Africa

See all

Related on diagnostics and lab testing and neonatal

See the topic